| Literature DB >> 35187421 |
Anja Vogelmann1, Manfred Jung1, Finn K Hansen2, Matthias Schiedel3.
Abstract
The tubulin deacetylases Sirt2 and HDAC6 have been associated with the development of various diseases. Herein, we discuss recent approaches that enable cellular target engagement studies for these deacetylases and thus play a critical role in the evaluation of small molecule inhibitors of Sirt2 or HDAC6 as potential therapeutic agents.Entities:
Year: 2022 PMID: 35187421 PMCID: PMC8844959 DOI: 10.1021/acsptsci.2c00004
Source DB: PubMed Journal: ACS Pharmacol Transl Sci ISSN: 2575-9108